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Epilepsy
Abstract
High-frequency (100–500 Hz) oscillations (HFOs) recorded from intracranial electrodes are a potential
biomarker for epileptogenic brain. HFOs are commonly categorized as ripples (100–250 Hz) or fast ripples
(250–500 Hz), and a third class of mixed frequency events has also been identified. We hypothesize that
temporal changes in HFOs may identify periods of increased the likelihood of seizure onset. HFOs (86,151)
from five patients with neocortical epilepsy implanted with hybrid (micro + macro) intracranial electrodes
were detected using a previously validated automated algorithm run over all channels of each patient's entire
recording. HFOs were characterized by extracting quantitative morphologic features and divided into four
time epochs (interictal, preictal, ictal, and postictal) and three HFO clusters (ripples, fast ripples, and mixed
events). We used supervised classification and nonparametric statistical tests to explore quantitative changes
in HFO features before, during, and after seizures. We also analyzed temporal changes in the rates and
proportions of events from each HFO cluster during these periods. We observed patient-specific changes in
HFO morphology linked to fluctuation in the relative rates of ripples, fast ripples, and mixed frequency
events. These changes in relative rate occurred in pre- and postictal periods up to thirty min before and after
seizures. We also found evidence that the distribution of HFOs during these different time periods varied
greatly between individual patients. These results suggest that temporal analysis of HFO features has potential
for designing custom seizure prediction algorithms and for exploring the relationship between HFOs and
seizure generation.
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 35 
Abstract 36 
High frequency (100-500 Hz) oscillations (HFOs) recorded from intracranial electrodes 37 
are a potential biomarker for epileptogenic brain. HFOs are commonly categorized as ripples 38 
(100-250 Hz) or fast ripples (250-500 Hz), and a third class of mixed frequency events has also 39 
been identified. We hypothesize that temporal changes in HFOs may identify periods of 40 
increased likelihood of seizure onset.  86,151 HFOs from five patients with neocortical epilepsy 41 
implanted with hybrid (micro + macro) intracranial electrodes were detected using a previously 42 
validated automated algorithm run over all channels of each patient’s entire recording. HFOs 43 
were characterized by extracting quantitative morphologic features and divided into four time 44 
epochs (interictal, preictal, ictal, and postictal) and three HFO clusters (ripples, fast ripples, and 45 
mixed events). We used supervised classification and nonparametric statistical tests to explore 46 
quantitative changes in HFO features before, during, and after seizures. We also analyzed 47 
temporal changes in the rates and proportions of events from each HFO cluster during these 48 
periods. We observed patient-specific changes in HFO morphology linked to fluctuation in the 49 
relative rates of ripples, fast ripples, and mixed frequency events. These changes in relative rate 50 
occurred in pre- and postictal periods up to thirty minutes before and after seizures. We also 51 
found evidence that the distribution of HFOs during these different time periods varied greatly 52 
between individual patients.  These results suggest that temporal analysis of HFO features has 53 
potential for designing custom seizure prediction algorithms and for exploring the relationship 54 
between HFOs and seizure generation. 55 
 56 
 57 
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 60 
Introduction 61 
High frequency oscillations (HFOs) have received increasing interest as a promising 62 
biomarker for epileptogenic tissue. HFOs are discrete electrophysiological events that stand out 63 
from background activity and are seen in normal as well as epileptic tissue (Engel et al. 2009). 64 
They occur in the 100-500 Hz frequency range and generally last on the order of tens of 65 
milliseconds. HFOs have conventionally been separated into two classes by frequency: ripples 66 
(100-250 Hz) and fast ripples (250-500 Hz), though a third class of mixed frequency events has 67 
been automatically identified in human neocortical epilepsy  (Blanco et al. 2010). Ripples were 68 
first identified during normal brain functions such as memory consolidation (Buzsaki 1998; 69 
Grenier et al. 2001; Siapas and Wilson 1998) but were later identified in epileptic tissue as well 70 
(Bragin et al. 2002a).  71 
The study of HFOs may help elucidate mechanisms of seizure generation (Demont-72 
Guignard et al. 2012; Jefferys et al. 2012). Many investigations have focused on the mechanisms 73 
generating ripples (Bragin et al. 2004; Bragin et al. 2007; Ylinen et al. 1995) and fast ripples 74 
(Dzhala and Staley 2004; Foffani et al. 2007; Ibarz et al. 2010; Menendez de la Prida and 75 
Trevelyan 2011). Fast ripples have been more closely linked to pathological activity and localize 76 
to the seizure onset zone (Bragin et al. 2002b; Urrestarazu et al. 2007). However, investigations 77 
of human intracranial recordings indicate that HFOs in both frequency ranges increase in 78 
epileptogenic brain regions (Jacobs et al. 2010; Worrell et al. 2008). Like seizures, HFOs 79 
increase after medication reduction, indicating a close link between the two phenomena 80 
(Zijlmans et al. 2009). These studies investigated HFOs primarily as a spatial biomarker, as they 81 
appear to have great potential for delineating epileptogenic brain. Removal of HFO-generating 82 
tissue has been shown to correlate with better outcomes of resective surgery (Akiyama et al. 83 
2011; Jacobs et al. 2010). However, one of the primary challenges in HFO research remains how 84 
to distinguish between normal and abnormal HFOs (Engel et al. 2009; Traub 2003); merely 85 
identifying fast ripples and ripples is not specific enough, as all types of HFOs are present even 86 
in normal human brain tissue (Blanco et al. 2011).  87 
 88 
One method of characterizing HFOs that has received relatively little attention is a 89 
detailed analysis of their temporal properties in the periods during and surrounding seizures. The 90 
seminal research on this subject has been encouraging. An in-vitro study demonstrated increased 91 
ripple and fast ripple activity before seizures (Khosravani et al. 2005).  Later human studies 92 
showed increased HFO activity 10 seconds before seizure onset (Zijlmans et al. 2011) and 93 
increased high-frequency power 8 seconds before seizure onset (Khosravani et al. 2009). 94 
Another investigation analyzing fifteen minutes preceding seizures found preictal changes in 95 
HFO rates and HFO-band power in all patients. However, the magnitude and direction of these 96 
changes were variable, and there were no clear systematic trends across patients and seizures 97 
(Jacobs et al. 2009). The majority of these analyses focused on counting the number of HFOs 98 
and determining the peak spectral content to classify them as ripples or fast ripples. We 99 
hypothesize that quantifying other features of HFO signals and evaluating them with more robust 100 
statistics provides information critical to characterizing HFOs.  This information could lead to 101 
new algorithms capable of predicting seizures or identifying abnormal areas of brain tissue.  102 
 103 
The current study evaluates HFOs as a temporal biomarker for seizures, analyzing 86,151 104 
events from five patients with neocortical epilepsy. HFOs were detected using an automated 105 
algorithm and grouped with unsupervised clustering (Blanco et al. 2010).  This method allows 106 
for processing massive datasets in a manner that minimizes human bias (Gardner et al. 2007).  107 
Using this dataset, we quantified waveform morphology using several signal processing features. 108 
These features were the basis for comparing the dynamics of HFOs in the epochs surrounding 109 
seizures, using several supervised classifiers and nonparametric statistical tests. The temporal 110 
changes in the rates of each type of HFO were also evaluated.  We find that each patient has 111 
unique, statistically significant temporal changes in HFO rates and features in the 30 minute 112 
period before and after seizures.  113 
 114 
Methods 115 
Patient Selection and Data Acquisition 116 
 We used a previously published HFO dataset (Blanco et al. 2010). Nine patients 117 
diagnosed with medically refractory epilepsy were implanted with subdural electrodes (Ad-Tech 118 
Medical Instruments, Racine, WI). As the goal of the analysis was to characterize HFOs at 119 
different times relative to seizure onset, for inclusion in the study we required the presence of at 120 
least one HFO during an electrographic seizure. Five of the nine patients met this study criterion. 121 
Three of those excluded did not have any seizures, and the fourth did experience any HFOs 122 
during the single seizure. Table 1 shows the clinical characteristics and electrode type for each of 123 
the five included patients. The experimental protocol involved medication taper but not sleep 124 
staging. 125 
 126 
Electrodes were modified versions of standard grid and strip electrodes with added arrays 127 
of non-penetrating, 40 μm platinum-iridium “micro” wires (Van Gompel et al. 2008). Besides 128 
intracranial electrodes, all patients received a limited montage of standard gold scalp electrodes, 129 
as well as other electrodes placed on the chin and anterior surface of the tibialis muscle to record 130 
electromyographic activity. Stainless steel surgical sutures (Ethicon, Somerville, NJ) located at 131 
the vertex region of the head served as the reference and ground for the intra- and extracranial 132 
electrodes. Data were acquired on a Digital Lynx Data Acquisition System (Neuralynx, 133 
Bozeman, MT) continuously at 32,556 samples per second with 18-bit resolution in up to 144 134 
channels per patient, with a 9-kHz low-pass anti-aliasing filter.  135 
 136 
HFOs were previously extracted from raw EEG data, as described in  (Blanco et al. 137 
2010). Briefly, we used a well-known HFO detector (Staba et al. 2002) to identify candidate 138 
events, then clustered them using an unsupervised algorithm that did not presuppose the number 139 
of subpopulations of HFOs.  This algorithm identified four clusters of HFOs, corresponding 140 
roughly to ripples, fast ripples, mixed events, and artifact. Events classified as artifacts were 141 
removed, and all remaining detected HFOs in each patient were used in the analysis. It is 142 
important to point out that the clustering algorithm removed filtering artifacts (Benar et al. 2010) 143 
and other nonphysiological waveforms with a success rate that was similar to trained human 144 
reviewers, who reviewed over 4700 individual HFOs in raw and filtered form. The algorithm 145 
was used on the entire dataset without modification for ictal versus interictal period.  The present 146 
work is comprised of all HFOs that were detected and validated in the previous paper (Blanco et 147 
al. 2010), excluding the artifacts.  The EEG data, as well as the HFO markings, are freely 148 
available at www.ieeg.org (Appendix A). 149 
 150 
Feature extraction  151 
Eight quantitative measures were calculated from each of the 86,151 remaining HFOs, a 152 
process known as feature extraction.  The features were: 1) fast ripple/ripple band power ratio; 2) 153 
spectral centroid; 3) spectral peak; 4) line length after spectral equalization; 5) bandpassed line 154 
length; 6) zero-crossings per sample length; 7) maximum amplitude; and 8) number of peaks per 155 
sample. The first four features characterize the frequency content of each event. The remaining 156 
four features capture elements of waveform morphology that distinguish HFO classes in 157 
published literature (see Appendix B). After calculating all features, we found that the data from 158 
features 7 and 8 were highly correlated with others (correlation > 0.84), but that the remaining 6 159 
provided unique information.  To reduce computational complexity, we used the reduced set of 6 160 
features for all analyses except the initial classification (next paragraph).  161 
 162 
HFO Ictal/Non-ictal Classification 163 
 We used three standard supervised machine-learning techniques to attempt to distinguish 164 
between HFO events occurring during ictal versus non-ictal periods: logistic regression, k-165 
nearest neighbors (k-NN), and a support vector machine (SVM). Each of these techniques uses a 166 
different algorithm to classify data.  The goal is to determine how to label HFOs automatically in 167 
subsequent data. We used two labels (ictal and non-ictal) in the first test to assess whether 168 
classification was feasible, and if more complex classification experiments aimed at seizure 169 
prediction would be possible. Information from all eight features was used to inform the 170 
classifiers, and we performed Principal Components Analysis (PCA) to lessen the computational 171 
burden on the learning algorithms. This reduced the eight features to five components while 172 
retaining 96.3% of the data variance. We ran the experiments on the aggregate patient data and 173 
on an individual patient basis. However, it is important to note that conclusive analyses were 174 
performed on the full feature set, rather than just PCA data (see below). We split each set of 175 
samples into equally-sized sets of training and testing data.  176 
 177 
To further simplify the initial test of the classifiers, we first trained them on data from 178 
each patient individually, with a segregated partition of testing data. We also trained and tested 179 
on data from all patients in aggregate.  In each case, we created ten random partitions from the 180 
training and testing data sets, reserving 25% of the samples in each data set for cross-validation. 181 
Appendix C describes the details of the cross-validation for the three methods. We assessed 182 
classifier performance on the testing data using the F1 measure (Eq. 1), the harmonic mean of 183 
sensitivity and precision:  184 
S = TP
TP+FN
 
          (1) 185 
P = TP
TP+FP
 
 186 
F1= 
2*S*P
S+P
 
 (S: sensitivity,  P: precision, TP: true positive, TN: true negative, FP: false positive) 187 
 188 
We used a permutation test to compare the testing set results to those generated by randomly 189 
assigned ictal/non-ictal labels. This tested the null hypothesis that the classification was no better 190 
than randomly assigning the labels.  After permuting the labels of the training data, we retrained 191 
the classifiers, then reclassified the testing data. We repeated this procedure for 10,000 trials for 192 
each patient and for 10,000 trials of the aggregate of all five patients. We compared the original 193 
F1 performance of the classifiers to the expected performance under the null hypothesis (the 194 
distribution of F1 from the random permutations) at a significance level α = 0.05 (Bonferroni 195 
corrected α = 0.001).  196 
 197 
Temporal distribution of HFO features 198 
After calculating all features, each HFO can be represented as a unique point in “feature 199 
space” that has as many dimensions as the number of features. We divided the HFOs into four 200 
time epochs: preictal, ictal, postictal, and interictal. Pre- and postictal windows were defined as 201 
10 minutes before and after a seizure, respectively. Interictal was defined as greater than 10 202 
minutes from a seizure for this test. We tested whether the distribution of HFOs within the 203 
feature space in each epoch was non-random. The null hypothesis was that the scattered 204 
distribution of features of all HFOs in each epoch was no different than if the HFOs were 205 
randomly assigned to an epoch.  The centroid of features 1-6 was calculated (7-8 were not 206 
included due to high correlation with the other features).  We measured the Euclidean distance of 207 
each HFO’s features to the centroids, grouped HFOs according to epoch, and used the median 208 
distance as the measure of dispersion for that epoch. We first calculated the dispersion using the 209 
original labels. We then randomly permuted the epoch labels, determined a new centroid for each 210 
of the four epochs, and recalculated the dispersion of all relabeled HFOs within that epoch, 211 
repeating this procedure over 10,000 trials. The probability of the null hypothesis (i.e. that the 212 
observed dispersion in each epoch was that of a random sample of all HFOs) was the proportion 213 
of permutations with dispersion values more extreme than the real data, tested with a 214 
significance level of 0.05.  Similar analyses were done with pre/postictal periods of several other 215 
durations from 2-120 minutes; results of this analysis were similar.   216 
 217 
Temporal evolution of HFO features 218 
 We assessed changes in the morphology features before and after seizures using two non-219 
parametric statistical tests that are resistant to outliers and/or skewed data. We first performed 220 
Principal Components Analysis (PCA) in each patient to reduce the set of HFO features to two 221 
dimensions for the purpose of visualization. We divided the four epochs above into smaller 5- to 222 
10-minute “stages” (10 total) between 0-30 minutes before and after seizures. Interictal for these 223 
analyses was defined as greater than 30 minutes from a seizure. We made scatter plots of the 224 
HFOs in the first two PCA dimensions for each stage. The Kruskal-Wallis Test of the first two 225 
PCA components determined whether the 2-dimensional PCA distributions from the different 226 
stages were unique versus samples of the same distribution. We then evaluated temporal changes 227 
of the six individual morphology features (see previous paragraph) using Spearman’s rank 228 
correlation, the nonparametric equivalent of the Pearson correlation. This test, which used 6 229 
features explicitly, served as a more robust analysis of the conclusions in the PCA data. This test 230 
determines whether there is a monotonic relationship between time and each feature. HFOs prior 231 
to the first seizure or after the last were excluded from this analysis, as their relationship to 232 
previous or subsequent seizures could not be determined.  233 
 234 
Stereotyped responses in different seizures 235 
We evaluated whether the temporal changes above were consistent from seizure to 236 
seizure within each patient with an analysis of variance (ANOVA) on the first two PCA 237 
components in each of the ten stages.  We calculated the variance of each component in each 238 
temporal stage for each seizure, then computed the ANOVA across all seizures in each patient.  239 
The ANOVA p-values were averaged across each patient and across each stage: high p-values 240 
indicate that the distributions are similar from seizure to seizure, i.e. that the response is 241 
stereotyped.  242 
 243 
Temporal evolution of HFO rate and class 244 
 In order to analyze temporal changes in the rates and proportions of each of the three 245 
HFO classes (ripples, fast ripples, mixed events (Blanco et al. 2010)), we calculated the average 246 
rate (events/minute) and percentage of total events from each HFO class within each of the 5- to 247 
10-minute stages described above. To quantify the relationship between HFO class and latency 248 
to seizure, we performed a Kruskal-Wallis test comparing the rank order of each class with time 249 
to nearest seizure, aggregating all seizures. This was done twice, evaluating time to next and time 250 
to previous seizure. A significant p-value (<0.05) indicates that the three clusters have different 251 
distributions, in other words that each class tends to occur at different times in relation to the 252 
nearest seizure.  We tested whether the preictal rates of each class change significantly from 253 
interictal baseline with a chi-square test, comparing the proportion of each type of HFO during 254 
interictal versus the combination of all preictal stages (0-30 minutes).  255 
 256 
Results 257 
HFO Ictal/Non-ictal Classification 258 
 The first analysis tested three classifiers to determine whether they could distinguish 259 
HFOs occurring during seizures (ictal) from those occurring at other times (non-ictal, including 260 
interictal, postictal, and preictal). Figure 1 shows how well each classifier was able to separate 261 
the morphology of ictal and non-ictal HFOs, which we quantified using the F1 measure. The 262 
logistic regression classifier is not included in the figure because it did not make a single true 263 
positive identification. A higher F1 score indicates a larger number of true positives relative to 264 
false positives and false negatives. The highest possible score is 1, resulting from perfect 265 
sensitivity and precision. The classifiers had limited success in separating the ictal and non-ictal 266 
HFOs. This is in part due to the fact that the proportion of non-ictal HFOs was much greater than 267 
ictal in the training data. The k-NN and SVM classifiers were statistically superior to random 268 
classification (0.05 significance, Bonferroni correction p << 0.001) in patients A and B, and the 269 
k-NN was superior to random classification in patient D and in the aggregate of all 5 patients. 270 
Thus, in certain patients it was possible to distinguish ictal from non-ictal HFOs better than 271 
random; however, the actual F1 scores were all < 0.2, suggesting the classification was not very 272 
sensitive nor precise.   273 
 274 
Temporal distribution of HFO features 275 
To evaluate whether any feature characteristics varied over time, we further subdivided 276 
the non-ictal period into postictal, preictal, and interictal epochs. Table 2 displays the number of 277 
HFOs in each epoch. Seizures were a mean of 120 minutes apart (range 9.5 to 839 min).  In three 278 
patients, some seizures occurred less than one hour apart, causing pre- and postictal periods to 279 
overlap. HFOs occurring during these overlaps were counted as both pre- and post-ictal events, 280 
which may introduce bias into some of the following analyses. However, this involved a small 281 
number of HFOs (15% of HFOs in patient A, none in B and C, and 1% in D and E), and 282 
removing them from analysis did not change any of the conclusions (next section). In each 283 
patient, we tested whether the distribution of HFOs in feature space was different during each 284 
epoch than what would be expected from a random sample of HFOs from all epochs in that 285 
patient. Figure 2 displays a plot of all HFOs from one patient, projected into two-dimensional 286 
feature space via PCA, with raw data from several HFOs displayed to demonstrate the varied 287 
appearance across the PCA space.  Figure 3 displays the same data separated into time epochs, 288 
showing that the HFO distribution in each epoch (i.e. the “shape” of the scattered HFOs) differs 289 
from the shape of the population as a whole. Similar findings were found in the other patients, 290 
though the distributions and rates of each HFO type were very different from this patient (see 291 
Fig. 6).  Though it cannot be displayed graphically, the HFO distributions using all six features 292 
have similar temporal differences. When analyzing the data in six dimensions (one for each 293 
feature), the distributions were significantly different than random: there were specific 294 
characteristics during the different epochs, demonstrated by a difference in cluster dispersion as 295 
measured by Euclidean distance (p < 0.05). We made similar temporal comparisons for each 296 
feature individually and found great inter-patient variability. Table 3 shows the p-values for two 297 
example features, the line length after spectral equalization and power band ratio. The other 298 
features demonstrated similar inter-patient variability and were significant in some, but never all, 299 
of the five patients. These results imply that HFO distributions vary during different peri-ictal 300 
epochs and involve complex relationships between several features, but that these changes are 301 
unique to individual patients. Thus, samples from different times, especially across different 302 
patients, will likely have different feature distributions.    303 
 304 
Temporal evolution of HFO features 305 
 The previous section tested whether each epoch had a different distribution from random.  306 
We next sought to test the time-dependency of HFO features. The first step was to compare the 307 
distributions in each stage in the 2-dimensional PCA plots (e.g. Fig. 3 for Patient C). The 308 
Kruskal-Wallis Test demonstrated that for all patients there were highly significant differences 309 
between stages (p << 0.0001). We then evaluated how the individual features changed 310 
temporally, using time before or after seizure as a continuous variable rather than constraining 311 
the analysis to categorical epochs. We used the Spearman correlation to assess whether there was 312 
any time dependence for each of the six individual features. The Spearman correlation 313 
determines strength and direction of any monotonic relationship between a feature and time; in 314 
this case, it assesses how much of a measureable, progressive change the HFO features have as a 315 
function of time prior or subsequent to seizure. Figure 4 shows the Spearman correlations for 316 
each patient. Correlations closer to ±1 indicate stronger relationships. In most cases, several 317 
features demonstrated weak but statistically significant correlations with both time to next 318 
seizure and time from previous seizure. Interestingly, certain features showed a significant 319 
positive correlation with time in some patients and a significant negative correlation with time in 320 
others.  These analyses were repeated in patients A, D, and E with the overlapping HFOs 321 
removed, and there were no substantive changes to the conclusions: Kruskal Wallis tests were 322 
still all significant, and there were minor changes to the Spearman correlations (Fig. 4B).  323 
In order for these temporal changes to be helpful in the development of customized 324 
seizure prediction algorithms, they must be consistent from seizure to seizure.  Looking at each 325 
patient individually, we evaluated the seizure to seizure variability by running ANOVA on the 326 
first two PCA components in each peri-ictal stage across all seizures. In this analysis, when the 327 
p-value is “insignificant” (> 0.05), it corresponds to a similar distribution of the PCA values in 328 
subsequent seizures, i.e., the response is stereotyped and thus the ANOVA fails to find a 329 
difference between them.  Conversely, a “significant” p-value indicates there are differences 330 
across seizures, so the distributions of PCA are not stereotyped.  An example of each case is 331 
shown in Fig. 5.  These plots demonstrate that some patients are stereotyped while others are not, 332 
but do not capture all of the temporal changes described in previous paragraphs. The HFO 333 
distributions are quite similar from different seizure periods for example, there are a large 334 
number of HFOs 20-30 minutes before seizure 3 with different morphology, so it would be 335 
difficult to predict seizure onset in this patient based upon these data. We calculated the ANOVA 336 
of the PCA distributions across different seizures in every stage for every patient to determine if 337 
the changes were stereotyped.  We found that three of the patients (A, B, E) had stereotyped 338 
responses across all stages (p>0.05) (Fig. 5C).  In the other two patients (C, D), the ANOVA 339 
found that at least one of the PCA components was significantly different between different 340 
seizures, meaning it would be hard to predict how the distribution would look in later seizures. 341 
Taken together, these data demonstrate that several HFO features are correlated with time, that 342 
these changes are often stereotyped, but that there is significant inter-patient variability.  343 
 344 
Temporal evolution of HFO rate and class 345 
 Although it is clear from these analyses that a wide set of features is helpful to 346 
describe HFOs and their temporal dynamics, the data also suggest that  the relative rate of each 347 
HFO cluster (ripple, fast ripple, mixed event) may differ between different stages. Constraining 348 
each HFO to one of 3 cluster labels removes most information about its dynamic features, but is 349 
also the most common way they are currently studied.  In order to evaluate any changes 350 
descriptively, we first plotted the relative rates of each HFO cluster, as well as the total HFO 351 
rate, for each patient in each stage (Fig. 6). We observed distinct patient-specific trends in the 352 
evolution of rates and proportions of each cluster before and after seizures. In three of the 353 
patients (A, B, D), the total number of HFOs is relatively constant until an increase during the 354 
ictal period, an effect less pronounced in patient B. But the individual HFO clusters behave quite 355 
differently in these three patients.  In A, there is a subtledrop in the proportional of ripples just 356 
before the seizures. B has a similar effect postictally.  In D, mixed events dominate preictally, 357 
but disappear during the seizures. Observing the datapoints from individual seizures shows that 358 
similar findings are seen at each seizure. Patients C and E have much smaller changes in total 359 
HFO rate, sometimes having fewer HFOs during seizures.  The only consistent change in patient 360 
C is increased mixed events and loss of ripples during seizures.  Patient E is difficult to evaluate 361 
with only 2 seizures, but tends to have a predominance of ripples preictally and mixed events 362 
immediately postictally. We tested whether the HFO rates changed significantly from baseline 363 
by comparing the proportion of each HFO cluster in the interictal stage with the aggregate of the 364 
4 preictal stages.  Patients C, D and E had very significant changes from baseline, while A and B 365 
did not (p<<0.0001, chi-square).In order to quantify the relationships between each type of HFO 366 
and time to seizure in Fig. 6, we compared the firing times of every HFO with a Kruskal-Wallis 367 
test using time to the previous and subsequent seizure as continuous variables.  This assesses by 368 
rank order whether there are trends in the temporal distribution of each HFO cluster in each 369 
patient. A significant result (p < 0.05) indicates that the firing times of the three clusters are 370 
unlikely to be randomly distributed—that at least one type of HFO (ripple, fast ripple, mixed 371 
event) is more likely to occur at specific times between seizures.  We found that HFO times both 372 
before and after seizures were significantly different in all patients and times  (Table 4, Kruskal-373 
Wallis Test, p < 0.05). Thus, in each patient specific types of HFOs became more or less likely to 374 
occur in the pre- and post-ictal periods. These findings demonstrate the strong temporal 375 
relationships HFOs have with seizures as well as the disparate patterns found in different 376 
patients.  377 
 378 
Discussion 379 
Peri-ictal HFO distributions vary greatly among patients 380 
Our current analysis evaluates properties of three classes of HFOs in four epochs (inter-, 381 
pre-, postictal, and ictal), collecting a large number of events in 5 patients.  This allowed a 382 
thorough comparison of the statistical characteristics of HFOs during these epochs. Our use of 383 
three classes of HFO is a slight departure from previous work on these types of oscillations in 384 
patients with epilepsy.  The first two classes are very similar to ripple and fast ripples, which are 385 
commonly recognized in the literature and were originally identified based upon their peak 386 
oscillation frequency.  In this work, we have included mixed events that were identified by an 387 
unsupervised algorithm (Blanco et al. 2010) as a third class, as their power spectra contain 388 
features of both ripples and fast ripples 389 
 390 
Our results show that the relative and absolute rates of each class of HFO changed in the 391 
periods before and after seizures, and that these effects varied greatly among patients (Fig. 6). 392 
The ictal period was most variable in terms of the number and type of HFOs. The total HFO rate 393 
increased in three of the patients during seizures, while in the other two patients it decreased in 394 
the preictal period.  Such disparities in preictal HFO rates have been identified previously 395 
(Jacobs et al. 2009); to our knowledge this is the first work evaluating the postictal and interictal 396 
periods as well. Interestingly, not all patients exhibited their highest total HFO rate during 397 
seizures. Fast ripple and mixed event rate increased beginning from 20-30 minutes prior to 398 
seizures in all patients but B.  Fast ripple rates increased postictally in patients B-E. Ripples were 399 
predominant in 3 patients, though the ratio of ripples to fast ripples changed significantly in the 5 400 
minutes before and after seizures.  The time between seizures was highest in patients B and C, 401 
but there are no clear patterns that distinguish these two patients from the others.  It is notable 402 
that there were no trends consistent among all 5 patients.  With such a small patient sample size 403 
identifying so many differences between individuals, it is likely a common occurrence for 404 
patients to have unique HFO distributions. The cause of these findings is not clear. There are two 405 
main possibilities.  The first is that behavior of HFOs during, between and after periods of 406 
seizure generation may be unique to a patient’s epileptic network or mechanism of epilepsy. Our 407 
analysis of PCA features (Fig. 5) revealed that at least three of the patients had unique responses 408 
that were stereotyped in different seizures, suggesting this may be true in some patients.  Another 409 
possibility is that these individualized patterns may be due in part to sampling error, as there is 410 
no uniform implant strategy for all patients, and the microwires which detected many of the 411 
HFOs are dispersed unevenly in the implanted grids. These questions could be explored further 412 
by a larger sample with different implantation strategies that maximize high resolution electrode 413 
coverage in the brain, or perhaps by guiding electrode placement through intraoperative mapping 414 
of HFO generating regions to augment standard electrode placement strategies. Whatever the 415 
cause, our findings suggest that each patient must be evaluated individually when using HFO 416 
rates as an electrical seizure biomarker. 417 
One intriguing possibility for future work lies in comparing the results from patients B 418 
and D, which had the most similar ictal responses in Fig. 6 (increased rate of HFO and ripples 419 
during seizure).  These two patients both had frontal cortical dysplasia (Table 1). Although this 420 
sample size is small, this result suggests that future work should aim to stratify patients by 421 
epileptic pathology, and perhaps common trends could be identified.  Adding patients with other 422 
types of epilepsy (e.g. mesial temporal sclerosis) would also provide crucial information. Such 423 
work would likely also benefit from additional features that were not present in the current 424 
analysis.   425 
 426 
HFO features during the ictal period, and seizure prediction 427 
We tested three machine learning algorithms with a large dataset of automatically 428 
detected HFOs to determine whether supervised classification could be used to identify 429 
differences between ictal and nonictal HFOs.  Using the measurements described in Appendix B, 430 
none of the algorithms obtained an F1 score higher than 0.2, which is fairly poor performance.  431 
This finding suggests that, at least with these tools and features, it is difficult to distinguish any 432 
HFO signal features that are specific to the ictal period.   433 
Despite the low performance, two methods did beat random chance, so we further 434 
investigated the temporal changes in HFOs in the peri-ictal period to determine the source of the 435 
differences. The first step was to analyze the HFO features in “feature space.”  When the HFOs 436 
were grouped together based upon stage, each patient’s HFO distribution had a unique shape in 437 
feature space that changed over time.  We found that these changes continued to evolve as much 438 
as 30 minutes before or after seizures. We tested these changes in several different ways: 439 
comparing the distributions of their PCA-reduced features, comparing their 6-dimensional 440 
distributions to the distributions of random samples, and determining the Spearman correlation 441 
of each feature with time before and after seizures. In each case, there was strong statistical 442 
evidence of measureable temporal changes in HFO features.   443 
These findings have significant implications for developing automated seizure prediction 444 
or warning algorithms. Although this analysis did not attempt to develop such an algorithm, it 445 
was performed on an unbiased sample of continuous EEG, thus simulating the “real-world” 446 
conditions necessary for such an algorithm to be successful.  Additionally, it is well known that 447 
classification algorithms used for seizure detection and prediction usually perform better with 448 
input from multiple orthogonal features; most of our analyses were based upon single or PCA-449 
reduced features. Future attempts to develop seizure prediction algorithms based upon 450 
combinations of these and other features may be very useful, but will need to be rigorously tested 451 
using independent testing and training sets with prolonged continuous intracranial EEG, 452 
comparing against chance predictors using established methods (Mormann et al. 2007; Snyder et 453 
al. 2008).  Furthermore, these data also suggest that these algorithms will be most effective if 454 
they are personalized for individual patients  based upon their unique features (Stacey and Litt 455 
2008).  For example, certain features might be relevant for one patient but not another, or the 456 
correlation of certain features with seizures might differ in strength or direction between patients. 457 
This will require a thorough analysis of HFO data on a per-patient basis before adjusting and 458 
applying the prediction algorithm. It will be critical to identify appropriate patients for such 459 
algorithms, and likewise not to abandon these techniques if they fail in some patients. 460 
 461 
Identifying abnormal, epileptic HFOs 462 
As HFOs have been identified in both normal and abnormal brain, it is imperative that 463 
any clinical decisions based upon them are able to distinguish whether they are markers of 464 
abnormal activity or not (Engel et al. 2009). To date, the primary clinical strategies proposed are 465 
to identify the electrodes with the highest number of HFOs (Jacobs et al. 2010) or to stratify 466 
HFOs into different categories based upon peak frequency (i.e. ripples 100-250 Hz, fast ripples > 467 
250 Hz) (Akiyama et al. 2011).  While such strategies are promising, they were based upon 468 
selected retrospective data, and there is considerable risk in basing prospective clinical decisions 469 
upon such data.  The primary concern is that HFOs also occur outside the seizure onset zone, 470 
even in patients who do not have epilepsy at all (Blanco et al. 2011). It is quite possible that any 471 
patient can have a region with a relatively higher HFO density, but that the increase could be due 472 
to local edema, physiological variation, or various other non-epileptic causes.  It is therefore 473 
crucial to develop a method of characterizing HFOs that are true markers of epileptic tissue. 474 
One characteristic of HFOs that has received relatively little attention is their temporal 475 
variation. A recent study evaluated HFOs and sharp waves with respect to seizures and found 476 
that, unlike sharp waves, HFO incidence changes similar to seizures (Zijlmans et al. 2009). This 477 
finding is intriguing in light of recent work investigating the mechanisms of abnormal HFOs and 478 
seizures.  Ripples were originally described in normal tissue (Ylinen et al. 1995), and are 479 
considered to be the product of fast synchronous firing of inhibitory potentials.  Conversely, later 480 
work in epileptic tissue has shown that “abnormal” HFOs are comprised of population spikes 481 
(Bragin et al. 2011).  This difference has led to a great deal of research to determine how 482 
epileptic HFOs are made (Jefferys et al. 2012).  But detailed physiological studies into these 483 
phenomena are extremely difficult with current technology.  Therefore, computational modeling 484 
has been used to confirm the role of population spikes in ripples (Stacey et al. 2011; Stacey et al. 485 
2009; Wendling et al. 2012) and fast ripples (Demont-Guignard et al. 2012; Ibarz et al. 2010; 486 
Roopun et al. 2010).  In each case, epileptic pathologies (i.e. increased excitation, decreased 487 
inhibition, abnormal coupling) cause the abnormal HFO to occur.  Wending et al. demonstrated 488 
that HFO characteristics change on a continuum from normal activity to seizure, depending upon 489 
the parameters (Wendling et al. 2012).  These realistic modeling studies suggest that epileptic 490 
pathologies will alter the appearance of HFOs, and predict that a wide range of parameters 491 
(Demont-Guignard et al. 2012; Stacey et al. 2009) can be responsible.  Our data demonstrate 492 
clinical evidence supporting this: that there are temporal changes in HFO morphology leading 493 
into seizures.  These data likely represent a change in underlying physiology that is not yet 494 
quantified, which suggests that a robust feature analysis of HFOs may be able to illuminate 495 
future research into the underpinnings of this phenomenon.   496 
If one assumes that there is an underlying process that alters the network parameters 497 
before and after seizures, and that it affects both seizures and HFOs, it follows that HFOs may 498 
have different features in the time surrounding seizures.  Until technology is able to characterize 499 
these network phenomena on smaller scales, our best method is to analyze EEG data.  In this 500 
study, we analyze an unbiased sample of intracranial EEG and find that there are indeed 501 
temporal changes in HFO characteristics.  However, the differences were relatively small and 502 
were highly variable between patients.  Further work evaluating different signal features, 503 
recording EEG on different spatial and temporal scales, and comparing HFOs from “normal” and 504 
“abnormal” regions may be better able to distinguish these changes and lead to understanding of 505 
the mechanisms involved in generating both HFOs and seizures.  506 
 507 
Conclusion 508 
With increasing interest in and evidence for HFOs as an electrical seizure biomarker, it is 509 
crucial to develop automated methods to identify and classify them that are not operator 510 
dependent, and that can be applied to a wide range of patients as well as animal models. Using 511 
data from an automated HFO detection algorithm, this study provides statistical evidence that 512 
some patients demonstrate temporal changes in the distribution of HFOs in the periods before 513 
and after seizures. Initially, these findings can be the basis of further experimental algorithms to 514 
explore temporal phenomena such as seizure generation, prediction, and epileptogenesis.  With 515 
further validation, they may also provide a basis for algorithms capable of identifying periods of 516 
increased risk of seizure onset.  Perhaps the most important finding from this study is that 517 
individual patients have vastly different HFO patterns related to seizures; these findings suggest 518 
that any clinical decision based upon HFO analysis must be customized to each individual 519 
patient.   520 
 521 
 522 
 523 
Figure Legends 524 
Figure 1: Classifier performance for the aggregate patient data and for individual patients as 525 
measured by the F1 score, the harmonic mean of sensitivity and precision (max=1). Statistical 526 
significance at the level of α = 0.05 (Bonferroni corrected α = 0.001) is indicated by an asterisk. 527 
Results from the logistic regression classifier are not shown because the F1 score was zero in 528 
every trial.  SVM: support vector machine; k-NN: k-Nearest Neighbor. 529 
 530 
Figure 2: Scatter plot of all HFOs in Patient C in the first two dimensions of the PCA space. 531 
Each dot represents one HFO and is colored according to HFO cluster as determined by (Blanco 532 
et al. 2010). Localization of each dot corresponds to the first and second PCA components 533 
plotted in x-y coordinates. Representative waveforms from different regions of the PCA feature 534 
space provide examples of the morphology at each location. 535 
 536 
Figure 3: Outside: Scatter plots of the HFOs in each time stage for Patient C in the first two 537 
dimensions of the PCA space. Color indicates HFO cluster as in Fig. 2. Bar graphs show the 538 
average rate (events per minute) for each cluster. Center: Scatter plot of all HFOs from Patient C.  539 
 540 
Figure 4: A: Bar graphs showing the Spearman correlations for morphology features and time to 541 
next seizure (left) and time from previous seizure (right). Statistically significant correlations (α 542 
= 0.05) are indicated by an asterisk.  B: Repeat analysis when overlapping HFOs are removed.  543 
Patient B and C had none so the analysis was unchanged (italics).  Black circles indicate subtle 544 
differences from A, most notably that two values in patients A and D become significant 545 
(p<0.05).  Kruskal Wallis tests all remained p < 0.001 when overlappers were removed (not 546 
shown). 547 
 548 
 549 
Figure 5: Temporal HFO distributions are stereotyped across different seizures in some patients.  550 
HFOs are displayed by their first two principle components and stratified by seizure.  Plot is 551 
similar in organization to Fig. 3, but coloring corresponds to nearest seizure. A: In patient C, 552 
there are distinct patterns seen before or after certain seizures, such as 30-20 minute preictally in 553 
seizure 3. This patient does not have stereotyped HFO distributions (p<0.05).  B: Patient A has 554 
very similar distribution across all seizures in every stage, a stereotyped response (p>0.1).  All 555 
plots have same axes and scale, shown in lower left (bars: 1 unit).  C: P-values for the ANOVA 556 
of the first two PCA components. Bar graphs of average p-value across all stages except 557 
interictal in each patient. Bars indicate one standard deviation (n=9 stages).  Asterisks indicate 558 
statistical significance (p < 0.05) Insignificant p-values correspond to similarity in the 559 
distributions.  560 
 561 
 562 
Figure 6: Graphs of the relative rates of HFOs in each frequency cluster (orange, blue, and pink 563 
lines; left axis) and the total HFO rate (dotted dark line; right axis). Rates of each HFO cluster 564 
during individual seizures are indicated with indicated symbols; lines indicate mean across all 565 
seizures.  Error bars: standard deviation of total rate.  Lack of any consistent trends among 566 
different patients implies that there is marked inter-patient variability in HFO rates before and 567 
after seizures. Clustering of datapoints from different seizures indicates stereotyped responses, 568 
most prominent in patients A, B and D.  #- Chi-square testing indicated that proportions of each 569 
HFO cluster are significantly different from interictal in the patients C, D, and E.  Parentheses 570 
next to patient name indicate number of seizures in each patient. 571 
 572 
 573 
 574 
Tables 575 
Table 1: Patient summary 576 
 577 
Summary of patient clinical characteristics and electrode placement.  Parentheses: labels used in 578 
prior study, see Table 1 in (Blanco et al. 2011) for further details.  579 
 580 
 581 
  582 
Subject Age Sex Pathology Electrodes Electrode Placement 
A 
(SZ01) 
35 F Frontal neocortical 
oligodendroglioma 
Standard:  6x6  
Micro: 1x8  
Right: frontal, motor cortex 
B 
(SZ02) 
24 M Frontal cortical 
dysplasia 
Standard: 6x6  
Micro: 4x6  
Left: frontal, frontoparietal 
C 
(SZ04) 
39 F Temporal 
neocortical gliosis 
Standard:  6x6, 1x8, 
1x8, 1x4, 1x4, 1x4  
Micro: 1x4  
Left: temporal, inferior frontal, superior 
frontal, anterior temporal, posterior 
temporal, anterior, posterior 
D 
(SZ07) 
42 F Frontal cortical 
dysplasia 
 
Standard: 6x8, 3x8, 
1x4  
Micro: 1x4, 1x8 
Right: frontal, temporal, anterior 
temporal, inferior temporal, posterior 
temporal 
E 
(SZ08) 
38 F Temporal 
neocortical gliosis 
Standard:  6x6  
Standard depth:  
1x4  
Micro depth: 1x4, 
1x4  
Left: temporal, anterior temporal, 
middle temporal, posterior temporal 
Table 2: HFO and seizure counts 583 
 584 
Patient Total 
seizures 
Total 
HFOs 
Inter-
ictal 
Preictal Ictal Post-
ictal
A 9 2552 1487 314 371 380
B 3 9905 9237 280 139 249
C 4 12417 11585 329 317 186
D 7 53015 49519 1787 433 1276
E 2 8262 7210 493 46 513
All 25 86151 79038 3206 1306 2604
 585 
Counts of HFOs in each time epoch for dispersion analysis. Preictal and postictal epochs were 586 
defined as 10 minutes before and after seizures, respectively. 587 
 588 
 589 
 590 
Table 3: Dispersion p-values from 2 features 591 
 592 
 Feature 3 (Line length) 
 Pt A Pt B Pt C Pt D Pt E All 
Interictal 0.0018 * * * 0.0011 *
Preictal 0.3713 0.0615 * * 0.0002 0.2242
Ictal 0.0426 0.0007 * 0.3148 0.0155 *
Postictal 0.0983 * * 0.0038 * *
 593 
 Feature 4 (Power Band Ratio) 
 Pt A Pt B Pt C Pt D Pt E All 
Interictal * 0.2285 * * * 0.1398
Preictal 0.0442 0.4916 * * 0.4208 *
Ictal * 0.0001 * * * *
Postictal * 0.1059 * * * 0.3285
 594 
 595 
Table 3: P-values from the epoch dispersion analysis. Values were calculated by dividing the 596 
number of permutation test trials with results more extreme than the true values by the total 597 
number of permutation test trials (10,000). Bold text indicates values that were not statistically 598 
significant. The combination of all (six) features was significant in all patients. Each patient had 599 
different trends with the individual features.  Asterisks: highly significant (p < 1e-6) 600 
 601 
  602 
Table 4: P-values of temporal rank 603 
 604 
  
Time to 
Next 
Time From 
Previous 
Closest 
cluster (next) 
Pt A <.0001* <.0001* FR, M 
Pt B   0.013* <.0001* M, R 
Pt C <.0001* <.0001* FR, R 
Pt D <.0001* <.0001* FR, R 
Pt E <.0001* <.0001* R 
 605 
 606 
Table 4: P-values from the second Kruskal-Wallis Test, used to assess whether an HFO near a 607 
seizure was more likely to be of a specific cluster. Third column indicates which clusters were 608 
closest to the next seizure (R: ripple, M: mixed, FR: fast ripple ). Asterisks: statistical 609 
significance. 610 
 611 
  612 
Appendix A: Online access to data at www.ieeg.org 613 
The EEG data and HFO markings used in this study have been posted by the authors of (Blanco 614 
et al. 2011) for viewing and analysis on the IEEG-Portal (https://www.ieeg.org).  This free online 615 
database allows the user to view, download, and annotate EEG data, and has been established to 616 
allow datasharing and collaboration.  The five studies used in this manuscript can be accessed 617 
with the following names: 618 
Patient A- I001_P034_D01;  Patient B- I001_P011_D01;  Patient C- I001_P015_D01;  Patient 619 
D- I001_P014_D01;  Patient E- I001_P017_D02. 620 
 621 
 622 
Appendix B: Feature Equations 623 
 624 
1) Power Band Ratio (250-500 Hz)/(100-200 Hz): The ratio of estimated power in the 625 
hypothesized “fast-ripple” band to that in the hypothesized “ripple” band. Computed on the 626 
band-passed data; frequency-input domain. 627 
 628 
Power band ratio= P[250,500] P[100,200] 
where 629  ,  | |  , | 0, 2  
and Mk is a multitaper power spectral density estimate. For more details, see Blanco et al. 2010. 630 
 631 
2) Spectral Centroid: The frequency corresponding to the “center of mass” of the spectrum. 632 
Computed on the band-passed data; frequency-input domain. 633 
 634 
Spectral centroid= 
∑ kNT |Mk|2N/2k=0∑ |Mk|2N/2k=0  
 635 
3) Spectral Peak: The frequency corresponding to the peak of the estimated power spectral 636 
density. Computed on raw data; frequency-input domain. 637 
 638    1 | | ,  0, 1, … 2  
 639 
4) Line length after spectral equalization: Detections are first detrended and energy normalized 640 
by dividing by their Euclidean lengths and by sample length. Computed on raw data after first-641 
order backward differencing; time-domain input. 642 
Line length = 1
L
|xi-1-xi|
L-2
i=0
 
 643 
 644 
5) Line length (bandpassed) per sample length: line length of the 100-500 Hz bandpassed HFO 645 
waveform divided by the total length of the sample 646 
Line length bandpassed  per sample length= 
1
N
|xi-xi-1|
N
i=2
 
6) Zero-crossings per sample length: the number of times the sample crosses its mean divided by 647 
the total length of the sample, which is zero-meaned 648 
 649 
Zero crossings per sample = 1
N
 sign xi-1 ≠sign xi
N
i=2
 
 650 
7) Maximum amplitude range: the difference between a sample’s maximum and minimum 651 
values 652 
Max. amplitude range= max x - min(x) 
 653 
8) Number of peaks per sample length: the total number of local maxima in a sample divided by 654 
the total length of the sample 655 
No. peaks per sample = 1
N
 (xi>xi-1^ xi>xi+1)
N-1
i=2
 
656 
Appendix C: Classifier Cross Validation 657 
The k-NN classifier requires specification of the value for k, the number of nearest neighbors to 658 
use. We determined the optimal k by calculating the average performance of the classifier for a 659 
range of k values (from 1 to 20) over the ten partitions of training and validation data and 660 
selecting the input parameter that corresponded to the best average performance. We similarly 661 
obtained optimal parameters for the support vector machine (SVM) classifier, which requires 662 
specification of a) a cost parameter, C, that controls the tradeoff between reducing training errors 663 
and controlling the complexity of the model, and b) a parameter, γ, that controls the width of the 664 
Gaussian kernel. The latter two classifiers were re-trained on the augmented training and 665 
validation data using these optimal parameters. We did not optimize any parameters for the 666 
logistic regression classifier. 667 
 668 
 669 
  670 
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Table 1: Patient summary 
 
Summary of patient clinical characteristics and electrode placement.  Parentheses: labels used in 
prior study, see Table 1 in (Blanco et al. 2011) for further details.  
Subject Age Sex Pathology Electrodes Electrode Placement 
A 
(SZ01) 
35 F Frontal neocortical 
oligodendroglioma 
Standard:  6x6  
Micro: 1x8  
Right: frontal, motor cortex 
B 
(SZ02) 
24 M Frontal cortical 
dysplasia 
Standard: 6x6  
Micro: 4x6  
Left: frontal, frontoparietal 
C 
(SZ04) 
39 F Temporal 
neocortical gliosis 
Standard:  6x6, 1x8, 
1x8, 1x4, 1x4, 1x4  
Micro: 1x4  
Left: temporal, inferior frontal, superior 
frontal, anterior temporal, posterior 
temporal, anterior, posterior 
D 
(SZ07) 
42 F Frontal cortical 
dysplasia 
 
Standard: 6x8, 3x8, 
1x4  
Micro: 1x4, 1x8 
Right: frontal, temporal, anterior 
temporal, inferior temporal, posterior 
temporal 
E 
(SZ08) 
38 F Temporal 
neocortical gliosis 
Standard:  6x6  
Standard depth:  
1x4  
Micro depth: 1x4, 
1x4  
Left: temporal, anterior temporal, 
middle temporal, posterior temporal 
Table 2: HFO and seizure counts 
 
Patient Total 
seizures 
Total 
HFOs 
Inter-
ictal 
Preictal Ictal Post-
ictal
A 9 2552 1487 314 371 380
B 3 9905 9237 280 139 249
C 4 12417 11585 329 317 186
D 7 53015 49519 1787 433 1276
E 2 8262 7210 493 46 513
All 25 86151 79038 3206 1306 2604
 
Counts of HFOs in each time epoch for dispersion analysis. Preictal and postictal epochs were 
defined as 10 minutes before and after seizures, respectively. 
 
 
 
 
Table 3: Dispersion p-values from 2 features 
 
 Feature 3 (Line length) 
 Pt A Pt B Pt C Pt D Pt E All 
Interictal 0.0018 * * * 0.0011 *
Preictal 0.3713 0.0615 * * 0.0002 0.2242
Ictal 0.0426 0.0007 * 0.3148 0.0155 *
Postictal 0.0983 * * 0.0038 * *
 
 Feature 4 (Power Band Ratio) 
 Pt A Pt B Pt C Pt D Pt E All 
Interictal * 0.2285 * * * 0.1398
Preictal 0.0442 0.4916 * * 0.4208 *
Ictal * 0.0001 * * * *
Postictal * 0.1059 * * * 0.3285
 
 
Table 3: P-values from the epoch dispersion analysis. Values were calculated by dividing the 
number of permutation test trials with results more extreme than the true values by the total 
number of permutation test trials (10,000). Bold text indicates values that were not statistically 
significant. The combination of all (six) features was significant in all patients. Each patient had 
different trends with the individual features.  Asterisks: highly significant (p < 1e-6) 
 
Table 4: P-values of temporal rank 
 
  
Time to 
Next 
Time From 
Previous 
Closest 
cluster (next) 
Pt A <.0001* <.0001* FR, M 
Pt B   0.013* <.0001* M, R 
Pt C <.0001* <.0001* FR, R 
Pt D <.0001* <.0001* FR, R 
Pt E <.0001* <.0001* R 
 
 
Table 4: P-values from the second Kruskal-Wallis Test, used to assess whether an HFO near a 
seizure was more likely to be of a specific cluster. Third column indicates which clusters were 
closest to the next seizure (R: ripple, M: mixed, FR: fast ripple ). Asterisks: statistical 
significance. 
 
 
  
 
